
The FDA have approved Zealand Pharma’s Zegalogue therapy for the treatment of severe hypoglycemia in patients with diabetes.

Danish biopharmaceutical company Zealand Pharma has appointed Hanne Leth Hillman as VP of investor relations and corporate communications. She will …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

